MediPharm Labs (TSE:LABS) Hits New 52-Week Low – Should You Sell?

MediPharm Labs Corp. (TSE:LABS)’s share price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as C$0.06 and last traded at C$0.06, with a volume of 217558 shares trading hands. The stock had previously closed at C$0.07.

MediPharm Labs Price Performance

The company has a market capitalization of C$27.35 million, a P/E ratio of -3.25 and a beta of 0.31. The company has a debt-to-equity ratio of 1.45, a quick ratio of 3.10 and a current ratio of 3.21. The stock has a 50 day moving average price of C$0.07 and a 200 day moving average price of C$0.07.

MediPharm Labs (TSE:LABS) last released its earnings results on Thursday, November 13th. The company reported C($0.01) earnings per share for the quarter. MediPharm Labs had a negative net margin of 30.56% and a negative return on equity of 24.41%. The company had revenue of C$11.45 million for the quarter. Equities research analysts forecast that MediPharm Labs Corp. will post -0.04 earnings per share for the current fiscal year.

About MediPharm Labs

MediPharm Labs Corp, along with its subsidiaries, produces purified, pharmaceutical-like cannabis extracts and related derivative products. The company generates revenue from Private label, White label, the Tolling process, and others. Some of its vape brands are Northern Lights, Blue Dream Pink Kush and GG4.